TABLE 3.
Target | Forward sequence | Reverse sequence |
---|---|---|
MyHCIIa | 5′‐AGTCCCAGGTCAACAAGCTG‐3′ | 3′‐GCATGACCAAAGGTTTCACA‐5′ |
MyHCIIb | 5′‐AGTCCCAGGTCAACAAGCTG‐3′ | 3′‐TTTCTCCTGTCACCTCTCAACA‐5′ |
Myoglobin | 5′‐CTGTTTAAGACTCACCCTGAGAC‐3′ | 5′‐GGTGCAACCATGCTTCTTCA‐3′ |
Atrogin1 | 5′‐TGAGCGACCTCAGCAGTTAC‐3′ | 5′‐GCGCTCCTTCGTACTTCCTT‐3′ |
Col3a1 | 5′‐CCCAACCCAGAGATCCCATT‐3′ | 5′‐GGTCACCATTTCTCCCAGGA‐3′ |
SOD1 | 5′‐CATCAGCCCTAATCCATCTGA‐3′ | 5′‐CGCGACTAACAATCAAAGTGA‐3′ |
Il‐2 | 5′‐TAGGCCACAGAATTGAAAGATCT‐3′ | 5′‐GTAGGTGGAAATTCTAGCATCATC C‐3′ |
TATA box binding protein | 5′‐CCAATGACTCCTATGACCCCTA‐3′ | 3′‐CAGCCAAGATTCACGGTAGAT‐5′ |
Abbreviations: COL3A1, Collagen Type III Alpha 1 Chain; IL‐2, Interleukin 2;MyHCIIa, Myosin heavy chain IIa; MyHCIIb, Myosin heavy chain IIb; SOD1, Superoxide dismutase 1